Open access
Sep 2026
Harnessing endogenous carbon monoxide for cancer-selective drug synthesis
This study considerably advances the proof of concept for “therapeutic in vivo synthetic chemistry,” in which disease-associated metabolites are repurposed as structural building blocks for both diagnostic and therapeutic applications.
Masayuki Kawai, Tsung-Che Chang, Ambara R. Pradipta et al.
· Nature Communications · 0 citations